Quick Takeaways
- Cynthia Collins has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,345,640.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Cynthia Collins
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Cynthia Collins is at least $1,345,640 dollars as of 23 Jun 2025. Cynthia Collins is the Director of Certara, Inc. and owns shares of Certara, Inc. (CERT) stock worth about $713.2K. Cynthia Collins is the Director of CODEXIS, INC. and owns shares of CODEXIS, INC. (CDXS) stock worth about $282.6K. Cynthia Collins is the Director of MAXCYTE, INC. and owns shares of MAXCYTE, INC. (MXCT) stock worth about $192.5K. Cynthia Collins is the Director of DermTech, Inc. and owns shares of DermTech, Inc. stock worth about $157.3K.
- Signature
- /s/ David Sandoval, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Cynthia Collins and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Certara, Inc. ($713,237).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Cynthia Collins
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CERT | Certara, Inc. | Director | $713,237 | 21 May 2025 | ||
| CDXS | CODEXIS, INC. | Director | $282,635 | 10 Jun 2025 | ||
| MXCT | MAXCYTE, INC. | Director | $192,515 | 18 Jun 2025 | ||
| DMTK | DermTech, Inc. | Director | $157,253 | 01 Jun 2023 | ||
| PSTX | Poseida Therapeutics, Inc. | Director | $0 | 08 Jan 2025 |
Insider Transactions Reported by Cynthia Collins:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.